Bitterman Chris T. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 26, 2024
Insider Transaction Report
Form 4
Bitterman Chris T.
Vice Pres Sales & Marketing
Transactions
- Tax Payment
Common Stock
2024-03-23$1.81/sh−593$1,073→ 4,683 total - Award
Options (right to buy)
2024-03-25$1.71/sh+2,750$4,703→ 13,250 totalExercise: $1.71From: 2028-03-25Exp: 2034-03-25→ Common Stock (2,750 underlying)
Footnotes (1)
- [F1]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.